WHO Endorses Two New Ebola Vaccine Candidates for DRC Trials

The World Health Organization (WHO) has recommended two new vaccine candidates, ChAdOx1 BDBV and mRNA-1469, for inclusion in ongoing clinical trials in the Democratic Republic of Congo (DRC). These are the first vaccines specifically developed to combat the Bundibugyo Ebola virus, which has caused 5,163 deaths and 10,603 confirmed cases in the DRC as of November 2, 2026. This move aims to accelerate the development of effective tools against this specific Ebola strain.